ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
62 989,42
6,56%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Biolase Inc (BIOL)

  7. Biolase Inc (BIOL) Actualités

BIOL Biolase Inc

0,1499
0,0015 (1,01%)
Après les heures de négociation
Dernière mise à jour : 00:25:49
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Biolase Inc BIOL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0015 1,01% 0,1499 00:25:49
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,1488 0,1421 0,1498 0,1451 0,1484
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/3/202412:31EDGAR2Form PRE 14A - Other preliminary proxy statements
05/3/202412:05EDGAR2Form 8-K - Current report
27/2/202422:14EDGAR2Form 8-K - Current report
23/2/202422:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/2/202422:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/2/202413:01EDGAR2Form 8-K - Current report
15/2/202423:15EDGAR2Form 8-K - Current report
14/2/202419:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/2/202402:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202414:44EDGAR2Form S-1/A - General form for registration of securities..
07/2/202412:11EDGAR2Form S-1/A - General form for registration of securities..
07/2/202412:04EDGAR2Form 8-K - Current report
31/1/202403:57EDGAR2Form S-1/A - General form for registration of securities..
29/1/202423:01EDGAR2Form 8-K - Current report
29/1/202412:30PRNUSBIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023..
24/1/202423:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/1/202412:09EDGAR2Form S-1 - General form for registration of securities under..
08/1/202422:05PRNUSBIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO..
03/1/202422:05PRNUSBIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD
29/12/202322:05EDGAR2Form 8-K - Current report
26/12/202323:22EDGAR2Form S-1 - General form for registration of securities under..
14/12/202322:05PRNUSBIOLASE RECEIVES TOP WORKPLACES 2023 AWARD
12/12/202322:05PRNUSBIOLASE Successfully Concludes Waterlase iPlus All Tissue..
08/12/202315:25EDGAR2Form 8-K - Current report
08/12/202315:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202319:46PRNUSBIOLASE, Inc. Announces Pricing of $1.4 Million Registered..
17/11/202322:17EDGAR2Form 8-K - Current report
09/11/202322:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:20EDGAR2Form 8-K - Current report
09/11/202322:05PRNUSBIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY..
08/11/202312:30PRNUSLandmark Study Performed by the Independent McGuire..
07/11/202322:05PRNUSBIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9,..
18/10/202314:00PRNUSSWK Holdings Highlights Recent Achievements and Provides..
10/10/202321:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/9/202322:59EDGAR2Form 8-K - Current report
18/9/202322:30PRNUSBIOLASE Inc. Announces Closing of $4.5 Million Underwritten..
15/9/202323:27EDGAR2Form 424B1 - Prospectus [Rule 424(b)(1)]
15/9/202323:27EDGAR2Form 424B1 - Prospectus [Rule 424(b)(1)]
14/9/202315:08EDGAR2Form POS EX - Post-effective amendment adding exhibits to..
14/9/202305:16PRNUSBIOLASE Inc. Announces Pricing of $4.5 Million Underwritten..
14/9/202303:25EDGAR2Form S-1MEF - Registration adding securities to prior Form..
12/9/202321:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/9/202323:09EDGAR2Form S-1/A - General form for registration of securities..
30/8/202323:31EDGAR2Form S-1/A - General form for registration of securities..
10/8/202322:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:07EDGAR2Form 8-K - Current report
10/8/202322:05PRNUSBIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND..
02/8/202322:05PRNUSBIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON AUGUST 10,..
26/7/202322:38EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
BIOL
Biolase
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés